IRIDEX Debt to Equity Ratio 2010-2023 | IRIX
Current and historical debt to equity ratio values for IRIDEX (IRIX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. IRIDEX debt/equity for the three months ending December 31, 2023 was 0.00.
| IRIDEX Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2023-12-31 |
$0.03B |
$0.01B |
2.62 |
| 2023-09-30 |
$0.02B |
$0.01B |
1.90 |
| 2023-06-30 |
$0.02B |
$0.01B |
1.75 |
| 2023-03-31 |
$0.03B |
$0.02B |
1.58 |
| 2022-12-31 |
$0.03B |
$0.02B |
1.45 |
| 2022-09-30 |
$0.03B |
$0.02B |
1.49 |
| 2022-06-30 |
$0.03B |
$0.02B |
1.35 |
| 2022-03-31 |
$0.03B |
$0.02B |
1.25 |
| 2021-12-31 |
$0.03B |
$0.02B |
1.09 |
| 2021-09-30 |
$0.03B |
$0.03B |
1.00 |
| 2021-06-30 |
$0.02B |
$0.03B |
0.88 |
| 2021-03-31 |
$0.02B |
$0.03B |
0.93 |
| 2020-12-31 |
$0.01B |
$0.02B |
0.61 |
| 2020-09-30 |
$0.01B |
$0.02B |
0.65 |
| 2020-06-30 |
$0.01B |
$0.02B |
0.56 |
| 2020-03-31 |
$0.01B |
$0.02B |
0.46 |
| 2019-12-31 |
$0.01B |
$0.02B |
0.53 |
| 2019-09-30 |
$0.01B |
$0.02B |
0.50 |
| 2019-06-30 |
$0.01B |
$0.03B |
0.50 |
| 2019-03-31 |
$0.01B |
$0.03B |
0.48 |
| 2018-12-31 |
$0.01B |
$0.03B |
0.39 |
| 2018-09-30 |
$0.01B |
$0.03B |
0.34 |
| 2018-06-30 |
$0.01B |
$0.02B |
0.44 |
| 2018-03-31 |
$0.01B |
$0.03B |
0.37 |
| 2017-12-31 |
$0.01B |
$0.03B |
0.36 |
| 2017-09-30 |
$0.01B |
$0.04B |
0.24 |
| 2017-06-30 |
$0.01B |
$0.04B |
0.22 |
| 2017-03-31 |
$0.01B |
$0.04B |
0.19 |
| 2016-12-31 |
$0.01B |
$0.04B |
0.23 |
| 2016-09-30 |
$0.01B |
$0.04B |
0.24 |
| 2016-06-30 |
$0.01B |
$0.04B |
0.27 |
| 2016-03-31 |
$0.01B |
$0.03B |
0.24 |
| 2015-12-31 |
$0.01B |
$0.03B |
0.24 |
| 2015-09-30 |
$0.01B |
$0.03B |
0.24 |
| 2015-06-30 |
$0.01B |
$0.03B |
0.24 |
| 2015-03-31 |
$0.01B |
$0.03B |
0.24 |
| 2014-12-31 |
$0.01B |
$0.03B |
0.24 |
| 2014-09-30 |
$0.01B |
$0.03B |
0.27 |
| 2014-06-30 |
$0.01B |
$0.03B |
0.25 |
| 2014-03-31 |
$0.01B |
$0.03B |
0.24 |
| 2013-12-31 |
$0.01B |
$0.03B |
0.30 |
| 2013-09-30 |
$0.01B |
$0.03B |
0.28 |
| 2013-06-30 |
$0.01B |
$0.02B |
0.30 |
| 2013-03-31 |
$0.01B |
$0.02B |
0.26 |
| 2012-12-31 |
$0.01B |
$0.02B |
0.32 |
| 2012-09-30 |
$0.01B |
$0.02B |
0.28 |
| 2012-06-30 |
$0.01B |
$0.03B |
0.26 |
| 2012-03-31 |
$0.01B |
$0.02B |
0.27 |
| 2011-12-31 |
$0.01B |
$0.02B |
0.43 |
| 2011-09-30 |
$0.01B |
$0.02B |
0.43 |
| 2011-06-30 |
$0.01B |
$0.02B |
0.41 |
| 2011-03-31 |
$0.01B |
$0.02B |
0.47 |
| 2010-12-31 |
$0.01B |
$0.02B |
0.50 |
| 2010-09-30 |
$0.01B |
$0.02B |
0.53 |
| 2010-06-30 |
$0.01B |
$0.02B |
0.53 |
| 2010-03-31 |
$0.01B |
$0.02B |
0.63 |
| 2009-12-31 |
$0.01B |
$0.02B |
0.88 |
| 2009-09-30 |
$0.01B |
$0.01B |
0.91 |
| 2009-06-30 |
$0.01B |
$0.01B |
0.98 |
| 2009-03-31 |
$0.02B |
$0.01B |
1.27 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.049B |
$0.052B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
